logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
G

Geert D’Haens

university of amsterdam

124H-index
1.6KPaper Count
7.4WCitation Count
Published Papers 622
Publication Date
logo
Etrasimod Treatment Modulates Circulating and Lymph Node-Derived Lymphocytes in Crohn’s Disease
errInternational Journal of Molecular Sciences
IF4.9
err2026-03-08
err0
errOAAI
errDimitrios Nikolakis; Maarten J. Pruijt; Jan Verhoeff; Floris A. E. de Voogd; Christoph Teichert; Rathi D. Ryan; Diogo Branquinho; Catherine Crosby; Marleen G.H. van de Sande; Joep Grootjans; Geert R. D'Haens
errShare
errSave
Selective SII<2/SII<3 inhibition reprograms pro-and antiinflammatory pathways in myeloid cells, improving autoimmune disease outcomes
errJCI Insight
IF6.1
err2026-02-09
err0
errOAAI
errDe Vos, Steve; Desroy, Nicolas; Bellaire, Susan J.; Fernandes, Anna Pereira; Lavazais, Stephanie; Merciris, Didier; Delachaume, Carole; Robin-Jagerschmidt, Catherine; Cosson, Adrien; Lazaryan, Angela; Van Osselaer, Nancy; Amantini, David; Peixoto, Christophe; Colli, Maikel L.; Van Eeckhoutte, Thomas; Hakonen, Tiina; Constant, Magali; Garcia-Hernandez, Alberto; Barron, Rahul; D'haens, Geert; Bocher, Wulf O.
errShare
errSave
Reply to London et al.
errGastroenterology
IF25.1
err2026-02-06
err0
PREAI
errGeert D’Haens; Mobolaji Olurinde
errShare
errSave
Appendicectomy versus switching to a JAK inhibitor in inducing remission in patients with active ulcerative colitis after biologic therapy failure (COSTA): 1-year results of a multicentre, prospective, cohort study
errThe Lancet Gastroenterology & Hepatology
IF38.6
err2026-01-06
err0
PREAI
errEva Visser; Maud A Reijntjes; Lianne Heuthorst; Merle E Stellingwerf; Rachel West; Koen van Dongen; Rogier M P H Crolla; Susan van Dieren; Jarmila D W van der Bilt; Willem A Bemelman; Geert R D'Haens; Christianne J Buskens
errShare
errSave
Fibroblast activation protein is selectively expressed by CD90+fibroblasts in inflammatory bowel disease-associated intestinal fibrosis
errJournal of Crohns & Colitis
IF8.7
err2026-01-01
err0
PREAI
errLartey, D.; Van Os, B.; Ke, B. J.; Van Wijnbergen, K.; De Hertogh, G.; Barnhoorn, M.; Matteoli, G.; Buskens, C. J.; Jarmilla, V. D. B.; D'haens, G.; Grootjans, J.; Wildenberg, M.; Lowenberg, M.
errShare
errSave
Unsupervised Machine Learning to Identify Distinct Response Patterns to Guselkumab in Participants With Crohn's Disease: Post Hoc Analysis of the Pooled GRAVITI and GALAXI 2/3 Studies
errAMERICAN JOURNAL OF GASTROENTEROLOGY
IF7.6
err2025-12-01
err0
PREAI
errDulai, Parambir S.; D'haens, Geert; Reinisch, Walter; Hart, Ailsa; Rani, Sudheer; Olurinde, Mobolaji; Van Rampelbergh, Rian; Gao, Long-Long; Yang, Zijiang; Hoops, Timothy; Valiathan, Chandni; Schreiber, Stefan
errShare
errSave
One Subcutaneous 2-ml Injection of Mirikizumab is Bioequivalent to Two 1-ml Subcutaneous Injections in Healthy Participants
errAdvances in Therapy
IF4
err2025-11-28
err0
errOAAI
errYuki Otani; Christopher D. Payne; Edward V. Loftus; Geert D’Haens; Shomron Ben Horin; Abhishek Upadhya K; Kristin Todd; Paola Pellanda; Galen Shi; Xin Zhang
errShare
errSave
Endoscopic response to subcutaneous infliximab by disease location: A post hoc analysis of the LIBERTY-CD study
errClinical Gastroenterology and Hepatology
IF12
err2025-11-22
err0
PREAI
errBruce E. Sands; Stefan Schreiber; Marla C. Dubinsky; Geert D’Haens; Bincy P. Abraham; Miguel Regueiro; Silvio Danese; Hyunsoo Park; Dong-Hyeon Kim; Young Nam Lee; Stephen B. Hanauer; Jean-Frédéric Colombel
errShare
errSave
Recommendations to Standardize the Conduct of Clinical Trials Evaluating Novel Therapies for Perianal Fistulizing Crohn’s Disease
errClinical Gastroenterology and Hepatology
IF12
err2025-11-19
err0
PREAI
errSudheer Kumar Vuyyuru; Jurij Hanzel; Mantaj S. Brar; Silvio Danese; Geert D'Haens; William A. Faubion; Brian G. Feagan; Ailsa Hart; Paulo G. Kotze; Matthew J. Lee; Remo Panaccione; Julian Panes; Laurent Peyrin-Biroulet; Jordi Rimola; Bruce E. Sands; Cynthia S. Santillan; Johnathan P. Segal; Jaap Stoker; Stuart A. Taylor; Susan Archer
errShare
errSave
Safety and pharmacokinetics of SOR102, an oral bispecific inhibitor of TNF and interleukin-23 in healthy participants and patients with ulcerative colitis: a first-in-human, double-blind, randomised, placebo-controlled, phase 1 trial
errThe Lancet Gastroenterology & Hepatology
IF38.6
err2025-11-13
err0
PREAI
errVipul Jairath; Silvio Danese; Geert R D’Haens; Brian G Feagan; Laurent Peyrin-Biroulet; Bruce E Sands; Ingrid Gaemers; Matt Westfall; Allyson Q Terry; Kevin J Roberts; Sara Barbat; Pamela Wedel; Jacqueline M Benson; Carlos Sattler
errShare
errSave
Efficacy and Safety with Upadacitinib by Baseline Corticosteroid Use in Patients with Moderately to Severely Active Crohn's Disease
errINFLAMMATORY BOWEL DISEASES
IF4.3
err2025-11-01
err1
errOAAI
errDubinsky, Marla C.; D'haens, Geert; Dewit, Olivier; Juillerat, Pascal; Panaccione, Remo; Fujii, Toshimitsu; Dubcenco, Elena; Lacerda, Ana Paula; Anyanwu, Samuel, I; Ford, Sharanya; Cunneen, Colla; Fish, Irina; Joshi, Namita; Garrison, Andrew; Loftus, Edward, V
errShare
errSave
Kinetics of intestinal ultrasound and shear-wave elastography to assess early response in ulcerative colitis patients treated with filgotinib
errJOURNAL OF CROHNS & COLITIS
IF8.7
err2025-11-01
err0
errOAAI
errPruijt, Maarten Jan; Teichert, Christoph; De Voogd, Floris Antonius; Janssen, Reimer Jacques; Lowenberg, Mark; Goetgebuer, Rogier Leon; D'haens, Geert Renaat; Gecse, Krisztina Barbara
errShare
errSave
Higher Vedolizumab Clearance Associates with Poor Therapeutic Outcomes during Intravenous Vedolizumab Maintenance Therapy in Crohn's Disease
errINFLAMMATORY BOWEL DISEASES
IF4.3
err2025-11-01
err0
PREAI
errAnjie, Suzanne, I; D'Haens, Geert R.; Baert, Filip; Bossuyt, Peter; Hoentjen, Frank; Clasquin, Esme; Molnar, Tamas; Lowenberg, Mark; Vermeire, Severine; Panetta, J. Carl; Dervieux, Thierry
errShare
errSave
Mucosal B Cell Expansion and Maturation Contribute to Colitis Pathogenesis
errINFLAMMATORY BOWEL DISEASES
IF4.3
err2025-11-01
err0
errOAAI
errFung, Ivan C. N.; Koelink, Pim J.; Mulders, Lieven G. M.; Admiraal, Iris; Verseijden, Caroline; Verhoeff, Jan; Wildenberg, Manon E.; Luo, Yi; D'haens, Geert R.; Li Yim, Andrew Y. F.; de Jonge, Wouter J.
errShare
errSave
Design and rationale for the VICTRIVA study: A randomized, double-blind, phase 3b study of vedolizumab in combination with upadacitinib in Crohn's disease
errCONTEMPORARY CLINICAL TRIALS COMMUNICATIONS
IF1.4
err2025-11-01
err0
errOAAI
errDanese, Silvio; Sands, Bruce E.; Feagan, Brian G.; Jairath, Vipul; Panaccione, Remo; Peyrin-Biroulet, Laurent; Irving, Peter M.; Schreiber, Stefan; Dotan, Iris; Ferrante, Marc; D'haens, Geert R.; Jones, Stephen; Freire, Marcelo; Lindner, Dirk; Adsul, Shashi; Oberai, Pooja; Colombel, Jean-Frederic
errShare
errSave
Vedolizumab in early and late Crohn's disease (LOVE-CD): a phase 4 open-label cohort study
errThe Lancet Gastroenterology & Hepatology
IF38.6
err2025-10-27
err0
PREAI
errGeert R D'Haens; Mark Löwenberg; Filip Baert; Peter Bossuyt; Tamás Molnár; Frank Hoentjen; Esmé Clasquin; Krisztina B Gecse; Melanie S Hulshoff; Gert De Hertogh; Matthias Lenfant; Lotte Oldenburg; Séverine Vermeire
errShare
errSave
An international consensus on the design of clinical trials for advanced combination treatment (ACT) in inflammatory bowel disease
erreClinicalMedicine
IF10
err2025-10-23
err0
errOAAI
errVirginia Solitano; Jurij Hanžel; Christopher Ma; Robert Battat; Tim Raine; Britta Siegmund; Laurent Peyrin-Biroulet; Bram Verstockt; Joana Torres; Saurabh Mehandru; Geert D'Haens; Malcolm Hogan; Federica Ungaro; Raja Atreya; Julian Panés; Remo Panaccione; Claire E. Parker; Bruce E. Sands; Brian G. Feagan; Silvio Danese; Vipul Jairath
errShare
errSave
Peripheral blood DNA methylation signatures to predict treatment response in Crohn's disease - Authors' reply
errThe Lancet Gastroenterology & Hepatology
IF38.6
err2025-10-08
err0
PREAI
errAndrew Y F Li Yim; Evgeni Levin; Wouter J de Jonge; Peter Henneman; Jack J Satsangi; Geert R D'Haens
errShare
errSave
Impact of Prior Biologic Exposure on Ozanimod Efficacy and Safety in the Phase 3 True North Clinical Trial
errAMERICAN JOURNAL OF GASTROENTEROLOGY
IF7.6
err2025-10-01
err2
PREAI
errSands, Bruce E.; Rubin, David T.; Loftus, Edward V.; Wolf, Douglas C.; Panaccione, Remo; Colombel, Jean-Frederic; Dignass, Axel; Regueiro, Miguel; Vermeire, Severine; Afzali, Anita; Lawlor, Garrett; Ahmad, Harris A.; Wu, Hsiuanlin; Osterman, Mark T.; Jain, Anjali; D'Haens, Geert
errShare
errSave
Patient-Level Dynamics of Clinical Response to Mirikizumab and Its Impact on Quality of Life: Analysis From the Vivid-1 Trial in Crohn's Disease
errAMERICAN JOURNAL OF GASTROENTEROLOGY
IF7.6
err2025-10-01
err0
PREAI
errSchreiber, Stefan; Vadhariya, Aisha; Clemow, David B.; Yu, Guanglei; Keefer, Laurie; Ananthakrishnan, Ashwin; D'Haens, Geert R.; Kochhar, Gursimran; Zang, Huaiyu; Moses, Richard E.; Deepak, Parakkal
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
W
William J. Sandborn
H-index: 199 · Papers: 2.1K
W
Willem M. de Vos
H-index: 193 · Papers: 1.3K
S
Stefan Schreiber
H-index: 192 · Papers: 1.9K
E
Eric Van Cutsem
H-index: 174 · Papers: 1.8K
S
Séverine Vermeire
H-index: 163 · Papers: 2.4K
View more